References
- Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 2002;107(2):76-94. PubMed | Google Scholar
- Marzocchi G, Castagnetti F, Luatti S et al. Variant Philadelphia translocations: molecular-cytogenetic chararcterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood. 2011 Jun 23;117(25):6793-800. PubMed | Google Scholar
- Huret JL. Complex translocations, simple variant
translocations and Ph-negative cases in chronic myelogenous
leukemia. Hum Genet. 1990 Oct;85(6):565-8. Google
Scholar
- Hagemeijer A, de Klein A, Gödde-Salz E et al. Translocation of c-abl to “masked” Ph in chronic myeloid leukemia. Cancer Genet Cytogenet. 1985 Oct;18(2):95-104. PubMed | Google Scholar
- Sokal JE, Cox EB, Baccarani M et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood. 1984 Apr;63(4):789-99. PubMed | Google Scholar
- Hasford J, Pfirrmann M, Hehlmann R et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J Natl Cancer Inst. 1998 Jun 3;90(11):850-8. PubMed | Google Scholar
- Hasford J, Baccarani M, Hoffmann V et al. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOBEUTOS score. Blood. 2011 Jul 21;118(3):686-92. PubMed | Google Scholar
- Hughes T, Deininger M, Hochhaus A et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood. 2006 Jul 1;108(1):28-37. PubMed | Google Scholar
- Baccarani M, Deininger MW, Rosti G et al. European
Leukemia Net recommendations for the management of
chronic myeloid leukemia: 2013. Blood. 2013 Aug 8;122(6):872-84. Google
Scholar
- Mkrtchyan H, Ghazaryan S, Avetisyan G et al. Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome. Oncol Rep. 2008 Jul;20(1):99-104. PubMed | Google Scholar
- Eyupoglu D, Bozkurt S, Haznedaroglu I, Buyukasik Y, Guven D. The impact of variant Philadelphia chromosome translocations on the clinical course of chronic myeloid leukemia. Turk J Haematol. 2016 Mar 5;33(1):60-5. PubMed | Google Scholar
- Mitelman F, Johansson B, Mertens F. Mitelman
database of chromosome aberrations in cancer. 2010. Accessed on 09
May 2016.
- Bakshi SR, Patel BP, Brahmbhatt MM et al. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML. Cancer Genet Cytogenet. 2009 Mar;189(2):142-3. PubMed | Google Scholar
- Okada M, Satake A, Kaida K et al. Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. Int J Hematol. 2011 Feb;93(2):243-246. PubMed | Google Scholar
- Nishii K, Usui E, Sakakura M et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet. 2001 Apr 1;126(1):8-12. PubMed | Google Scholar
- Bacher U, Haferlach T, Hiddemann W, Schnittger S, Kern W, Schoch C. Additional clonal abnormalities in Philadelphia-positive ALL and CMl demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression. Cancer Genet Cytogenet. 2005 Feb;157(1):53-61. PubMed | Google Scholar
- Virgili A, Brazma D, Reid AG, Howard-Reeves J, Valgañón M, Chanalaris A et al. FISH mapping of Philadelphia negative BCR/ABL1 positive CML. Mol Cytogenet. 2008 Jul 18;1:14. PubMed | Google Scholar